AbstractHepatic steatosis is often associated with insulin resistance as a hallmark of the metabolic syndrome in the liver. The present study investigated the effects of PPARα activation induced by fenofibrate (FB) on the relationship of insulin resistance and hepatic steatosis in mice fed a high-fat (HF) diet, which increases lipid influx into the liver. Mice were fed HF diet to induce insulin resistance and hepatic steatosis with or without FB. FB activated PPARα and ameliorated HF diet-induced glucose intolerance and hepatic insulin resistance without altering either hepatic steatosis or inflammation signaling (JNK or IKK). Interestingly, FB treatment simultaneously increased fatty acid (FA) synthesis (50%) and oxidation (66%, both p<0.0...
Fenofibrate (FBR), an oral medication used to treat dyslipidemia, is a ligand of the peroxisome prol...
The peroxisome proliferator-activated receptor alpha (PPARα) activator fenofibrate efficiently decre...
Obesity is characterized by lipid accumulation in distinct organs. Presently, fenofibrate is a commo...
Hepatic steatosis is often associated with insulin resistance as a hallmark of the metabolic syndrom...
Hepatic steatosis is often associated with insulin resistance as a hallmark of the metabolic syndrom...
AbstractHepatic steatosis is often associated with insulin resistance as a hallmark of the metabolic...
Endoplasmic reticulum (ER) stress is suggested to cause hepatic insulin resistance by increasing de ...
Endoplasmic reticulum (ER) stress is suggested to cause hepatic insulin resistance by increasing de ...
Endoplasmic reticulum (ER) stress is suggested to cause hepatic insulin resistance by increasing de ...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
The peroxisome proliferator-activated receptor alpha (PPAR alpha) activator fenofibrate efficiently ...
Peroxisome proliferator-activated receptor (PPAR) agonists are used for treating hyperglycemia and t...
Fenofibrate (FBR), an oral medication used to treat dyslipidemia, is a ligand of the peroxisome prol...
The peroxisome proliferator-activated receptor alpha (PPARα) activator fenofibrate efficiently decre...
Obesity is characterized by lipid accumulation in distinct organs. Presently, fenofibrate is a commo...
Hepatic steatosis is often associated with insulin resistance as a hallmark of the metabolic syndrom...
Hepatic steatosis is often associated with insulin resistance as a hallmark of the metabolic syndrom...
AbstractHepatic steatosis is often associated with insulin resistance as a hallmark of the metabolic...
Endoplasmic reticulum (ER) stress is suggested to cause hepatic insulin resistance by increasing de ...
Endoplasmic reticulum (ER) stress is suggested to cause hepatic insulin resistance by increasing de ...
Endoplasmic reticulum (ER) stress is suggested to cause hepatic insulin resistance by increasing de ...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alp...
The peroxisome proliferator-activated receptor alpha (PPAR alpha) activator fenofibrate efficiently ...
Peroxisome proliferator-activated receptor (PPAR) agonists are used for treating hyperglycemia and t...
Fenofibrate (FBR), an oral medication used to treat dyslipidemia, is a ligand of the peroxisome prol...
The peroxisome proliferator-activated receptor alpha (PPARα) activator fenofibrate efficiently decre...
Obesity is characterized by lipid accumulation in distinct organs. Presently, fenofibrate is a commo...